Post Menopausal Obese Women
Conditions
Brief summary
Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.
Detailed description
Control group (A): 1. Each participant will sign a consent form after receiving a detailed explanation about the procedure. 2. A blood sample will been taken by a nurse in a heparinized tube and delivered to lab within six hours. 3. BMI will been measured body weight(Kg) and height (m2) a. BMI= body weight (Kg)/ height (m2). 4. Waist circumference will be measured. 5. After one month blood analysis evaluation will be done to record the response to the routine medication. Training Procedure for group (B): 1. Each participant will sign a consent form after receiving a detailed explanation about the procedure. 2. A blood sample will been taken by a nurse in a heparinized tube and delivered to lab within six hours. 3. BMI will been measured body weight(Kg) and height (m2) a. BMI= body weight (Kg)/ height (m2). 4. Waist circumference will be measured. 5. The maximum heart rate will be determined from Tanaka formula (208- 0.7 \*age of the participant) * Then the exercise load will be determined according heart rate reserve of the participants ( maximum heart rate - resting heart rate). 6. Start with sitting resting without any effort for 5 min then Start at a low speed and intensity for 5 minutes to warm up the body. 7. Increase the speed and intensity for 10-30 seconds before dropping it back for 2-5 minutes and Repeat according to the intensity. 8. Finally, a five minutes of cooling down with no resistance had performed. 9. After one month blood analysis evaluation will be done to record the response to the routine medication.
Interventions
DEVICEElectronic Upper limb( body) ergometer
Electronic pedal for the upper limb using for training the upper body. Intensity, speed and resistance can be adjusted.
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
Participant
Intervention model description
Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.
Eligibility
Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* female aged 45-60 years old. * class 1 and 2 obesity. * post menopausal. * diagnosed as controlled diabetic. * diagnosed as controlled hypertensive.
Exclusion criteria
* uncontrolled diabetic. * uncontrolled hypertensive. * class 3 and morbid obesity. * mentally unstable person. * Any shoulder, hand and elbow orthopedic or neural disorders.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Effect of the upper body ergometer on arthrogenic index ( triglyceride/ high density lipoprotein) | after one month of the trial application | Effect of the upper body ergometer on arthrogenic index ( triglyceride/ high density lipoprotein) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Effect of the upper body ergometer on total body weight kg. | after one month of the trial application | Effect of the upper body ergometer on total body weight kg. |
| Effect of the upper body ergometer on estimated maximum heart rate(beat/min). | after one month of the trial application | Effect of the upper body ergometer on estimated maximum heart rate(beat/min). |
Countries
Egypt
Outcome results
None listed